Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings yield high or low?
The earnings yield of 0.83% is in line with its 1-year average of 0.82%, around the middle of its 1-year range (0.75%–0.89%).
As of 2026-10-06T12:55:35.572Z.
Calculation as of: 2026-10-06T12:55:35.572Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b9d80053686f16721d19c62710da14dda18ff2c6e5fba2adc15c1c35f0ac96a2
EARNINGS YIELD
0.83%
EARNINGS YIELD AVG TTM
N/A
EARNINGS YIELD AVG 3Y
N/A
EARNINGS YIELD AVG 5Y
N/A
EARNINGS YIELD AVG 10Y
N/A
EARNINGS YIELD AVG 15Y
N/A
EARNINGS YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.90%
median of 131 covered companies
CURRENT VS SECTOR MEDIAN
-78.72%
vs the sector median at left
Arcutis Biotherapeutics, Inc.
Market Cap
$3.15B
Earnings Yield
0.83%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.16B
Earnings Yield
N/A
TTM Avg
0.44%
3Y Avg
0.44%
5Y Avg
0.44%
Market Cap
$3.09B
Earnings Yield
N/A
TTM Avg
25.02%
3Y Avg
25.02%
5Y Avg
25.02%
Market Cap
$2.87B
Earnings Yield
4.65%
TTM Avg
3.82%
3Y Avg
2.33%
5Y Avg
2.33%
Market Cap
$3.44B
Earnings Yield
11.04%
TTM Avg
8.17%
3Y Avg
6.43%
5Y Avg
6.43%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | $3.15B | 0.83% | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | N/A | 0.44% | 0.44% | 0.44% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | N/A | 25.02% | 25.02% | 25.02% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.25B | N/A | N/A | N/A | N/A |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 4.65% | 3.82% | 2.33% | 2.33% |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 0.38% | 0.43% | 0.43% | 1.84% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | 11.04% | 8.17% | 6.43% | 6.43% |
| Celcuity Inc. (CELC)vs › | $3.59B | N/A | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 10.21% | 9.07% | 6.61% | 6.61% |
Earnings Yield
0.83%
EPS ÷ Price
P/E Ratio
120.6
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS YIELD |
|---|---|
| 2026-10-05 | 0.83% |
| 2026-10-02 | 0.83% |
| 2026-10-01 | 0.82% |
| 2026-09-30 | 0.79% |
| 2026-09-29 | 0.78% |
| 2026-09-28 | 0.76% |
| 2026-09-25 | 0.77% |
| 2026-09-24 | 0.79% |
| 2026-09-23 | 0.79% |
| 2026-09-22 | 0.75% |
| 2026-09-21 | 0.80% |
| 2026-09-18 | 0.82% |
| 2026-09-17 | 0.79% |
| 2026-09-16 | 0.80% |
| 2026-09-15 | 0.89% |
| 2026-09-14 | 0.86% |
| 2026-09-11 | 0.87% |
| 2026-09-10 | 0.89% |
| 2026-09-09 | 0.87% |
| 2026-09-08 | 0.85% |
| 2026-09-04 | 0.87% |
| 2026-09-03 | 0.88% |
| 2026-09-02 | 0.87% |
| 2026-09-01 | 0.88% |
| 2026-08-31 | 0.87% |
| 2026-08-28 | 0.88% |
| 2026-08-27 | 0.84% |
| 2026-08-26 | 0.83% |
| 2026-08-25 | 0.84% |
| 2026-08-24 | 0.84% |
| 2026-08-21 | 0.83% |
| 2026-08-20 | 0.82% |
| 2026-08-19 | 0.79% |
| 2026-08-18 | 0.79% |
| 2026-08-17 | 0.81% |
| 2026-08-14 | 0.80% |
| 2026-08-13 | 0.81% |
| 2026-08-12 | 0.79% |
| 2026-08-11 | 0.79% |
| 2026-08-10 | 0.80% |
| 2026-08-07 | 0.82% |
| 2026-08-06 | 0.79% |
